冠心病！顶尖医学技术成果呈现亮相

冠心病！

coronary disease!

顶尖医学技术成果呈现亮相

Top medical technology achievements are presented

冠心病是一种当代健康中的天敌，它涉及人口多，復盖面积广，顽疾隐藏深，疾病年轻化，治疗程度难，病发速度快，死亡概率高的一种高危度疾病。是属于心脑血管病中的大病范筹，更属于人类健康中的重大疾病之一，人们称它为恐怖的魔鬼疾病，悄悄地来，悄悄的走，时好时坏，无法捉摸。被医学界列为人类一号杀手一一一一，众所周知，冠心病不仅是我国的医学难题，也是世界各国的医学难题，至今还没有得到医学上有效的防范和治愈。人口众多的中国患者，只能依赖去医院治疗，医院除了用各种西药丶口服丹参滴凡药物控制一下病情以外，接着就是采用金属支架植入，搭桥手术给予治疗。人们称它为”三板斧”疗法，不管医院采取什么方式治疗，都没能将冠心病治愈，反而还会导致西药的毒副作用对人的内脏机体造成损伤。病人越治越多的现象累积成患，摆在医学事实面前，的确是一件非常棘手丶又无可奈何的大问题。

Coronary heart disease is a kind of natural enemy in contemporary health. It involves a high-risk disease with large population, wide cover area, deep hidden disease, younger disease, difficult treatment degree, fast speed of disease and high probability of death. It belongs to the cardiovascular disease, more belongs to one of the major diseases in human health, people call it a terrible devil disease, quietly come, quietly go, good and bad, elusive. As is known to all, coronary heart disease is not only a medical problem in China, but also a medical problem in other countries all over the world. So far, it has not been effectively prevented and cured in medicine. Chinese patients with a large population can only rely on going to the hospital for treatment. In addition to using various western medicines and oral Danfan drugs to control the condition, the hospital then uses metal stent implantation and bypass surgery for treatment. People call it "three board axe" therapy, no matter what way the hospital takes treatment, can not cure coronary heart disease, but will also lead to the toxic side effects of western medicine to the internal body damage. The phenomenon of more patients treated more accumulated, in front of medical facts, is indeed a very difficult, and helpless big problem.

目前，我国患有心血管病人潜伏者达2.9亿，每年1100万冠心病患者等待拯救，每年因冠心病死亡人数高达240万人，还有一些来不及到医院就心梗死亡的无法统计。

At present, there are 290 million cardiovascular patients in China, 11 million patients with coronary heart disease are waiting for rescue every year, the number of deaths from coronary heart disease is as high as 2.4 million, there are some deaths of myocardial infarction before the hospital to count.

冠心病是一种覆盖面积广，治疗程度难，涉及人口多，死亡概率高的奇特怪病，防又不能防，治又不能治愈，由此造成国人对冠心病产生极大的恐慌。更为滑稽的是许多医院心血管疾病的大夫医生丶专家自巳患上冠心病猝死之前，还在医院坐诊给冠心病患者看病治疗，自己都不能治好自已病，反而给别人治病，真是有些荒唐了。

Coronary heart disease is a kind of strange disease covering a wide area, the treatment degree is difficult, involving a large population, a high probability of death, prevention can not be prevented, cure can not be cured, resulting in a great panic of coronary heart disease. More funny is that many hospitals of cardiovascular disease doctors, experts have suffered from coronary heart disease sudden death before, but also in the hospital to see a doctor for coronary heart disease patients, they can not cure their own disease, but to treat others, it is really a little ridiculous.

所以，至今医学界一致认为，冠心病是一种不可预测丶不可预防丶不可治愈的一种疾病，心血管粥样硬化物一旦形成，任何药物都不可逆向，就是因为如此，支架植入手术治疗是冠心病急救治疗的一种手段，而这种急救手段只能控制一时，病根依然存在，冠心病何时重复暴发谁都不能预测。这就是冠心病可怕之处。那么，冠心病产生的主要途径原因又是如何呢？据卫生医学认为，一是不良生活习惯，长期的累积，二是食品安全无法得到保障，三是难以节制的大吃大喝，四是过度的劳累，铸成了冠心病井喷式的暴发。

So, the medical community agree that coronary heart disease is an unpredictable, preventable, incurable disease, cardiovascular atherosclerosis once formed, any drug cannot reverse, is because of this, stent implantation surgery is a means of emergency treatment of coronary heart disease, and this first aid means can only control, root still exist, coronary heart disease who repeat outbreak cannot predict. That's all about coronary heart disease. So, what is the main way to cause of coronary heart disease? According to health medicine, one is bad living habits, long-term accumulation, two is food safety can not be guaranteed, three is difficult to eat and drink, four is excessive fatigue, cast the coronary heart disease blowout outbreak.

冠心病养生素发明人——钟毓原

Coronary heart disease health care inventor of —— Zhong Yuyuan

深山藏奇妙！民间出高人

Mountain hidden wonderful! The folk are superior

由广西壮族自治区融水苗族自治县一位钟毓原老先生十五年前就洞察到冠心病往后的严重祸害，断定未来冠心病会更加猖狂，于是采用苗族草药，应用药食同源配伍的领悟，研究出中医药益生菌发酵方法，经过精心的培育和培养，成功研制出一种微生物养生素口服液，这种养生素口服液不但对人体无毒无害无副作用，而且口感鲜美，酸甜可口，入口清香，保鲜期长，能利尿通便，净化血液，清血化瘀，能清除人体垢物和血液垃圾，对心血管中的冠心病起到良好的预防丶保健丶治疗等多种功能作用，能对冠心病一丶二丶三级都能起到调理自愈，而且久不复发，根据不同的级别病情，能治愈率达90%以上。同时对人体多种慢性病调理起到独特的作用。被免了长期服西药及药毒的伤害和并发症，免去了支架植入手术丶搭桥手术的痛苦。钟老先生的发明创造，受益了当地许多因去医院治疗返病回归的病人，成为了当地的功德善人。

Mr.Zhong Yuyuan from Rongshui Miao Autonomous County, Guangxi Zhuang Autonomous Region had an insight into the serious disaster of coronary heart disease in the future 15 years ago, Determine that coronary heart disease will be more rampant in the future, So the miao herbs, The understanding of the same compatibility of medicine and food, Study on the fermentation method of TCM probiotics, After careful cultivation and cultivation, Successfully developed a microbial health hormone oral liquid, This health regimen oral liquid is not only non-toxic to human body without side effects, And it tastes delicious, Sweet and sour and delicious, Entrance fragrance, Long shelf life, Can diuretic and laxative, Purify the blood, Clear blood and stasis, Can remove human dirt and blood waste, Cardiovascular coronary heart disease in the good prevention, health care, treatment and other functions, Can the coronary heart disease one, two, three levels can play a conditioning self-healing, And without relapse, Depending on the level of illness, The cure rate is more than 90%. At the same time, it plays a unique role in the conditioning of a variety of chronic diseases. It was exempted from long-term use of western medicine and poison, and avoided the pain of stent implantation and bypass surgery. Mr.Zhong's invention and creation benefited many local patients who went to the hospital to return to illness, and became the local virtuous people.

由于钟老先生对冠心病院外临床试险取得了成功，产生了灵感，于是二0一三年向国家知识产权局提出申请了发明专利。专利局药学专家小组经过长达五年时间的反复论证，最后认定该发明具有创造性丶实用性`丶先进性的条件，符合国家专利法的规定，于二0一八年获得了国家知识产权颁发授予了发明专利，钟老先生的发明创新，为大健康医学科技向前推上了一个新的台阶.

As Mr.Zhong was inspired by the success of coronary heart disease, he applied for the invention patent to the State Intellectual Property Office in 2013. Patent office pharmaceutical expert team after five years of repeated argument, finally decided that the invention is creative, practical `, advanced, conform to the provisions of the national patent law, in 2018 won the national intellectual property awarded the patent for invention, the old gentleman invention innovation, for big health medical science and technology forward on a new step.

钟老先生上山采药照

Mr.Zhong went up to the mountain to collect medicine and photos

几年来，钟老先生在县城开设了中医药调理养生门店，许多患者都是从医院久治不愈返回来调理，每年数百名患者求助钟老先生用养生素治疗冠心病，百分之九十的人都一一得到了治愈康复的受益。如今，钟老先生73岁了，已进入了老年人行列，对于这个专利技术成果的实施推广已力不从心，没有精力亲自去布局推广全国冠心病人而感到了遗憾，为此，特将这个养生素口服液专利技术成果进行转化，给一些有能力丶有抱负丶有品德，有善心丶有志向丶有爰好中医药事业的企业家丶爱好大健康产业的人士`丶医药企业家接产推广。并欢迎各省市大健康工作者市场代理推广，使专利技术成果能普及发挥出更大的作用，去拯救更多的冠心病患者，去造福受益更多需求的人。

In the past few years, Mr.Zhong has opened a traditional Chinese medicine conditioning regimen store in the county seat. Many patients return from the hospital for a long time. Every year, hundreds of patients seek help from Mr.Zhong to treat coronary heart disease with health care regimen, and 90 percent of them have been cured and recovered. Today, the old man is 73 years old, has entered the elderly, the implementation of the patent technology promotion has inadequate, no energy to promote the coronary heart disease layout and feel regret, therefore, to the health element oral liquid patent technology achievements, give some ability, ambition, character, kindness, ambition, hence good Chinese medicine entrepreneurs, hobby big health industry `, pharmaceutical entrepreneurs production promotion. And welcome the provinces and cities big health workers market agent promotion, so that the patented technology results can play a greater role, to save more coronary heart disease patients, to benefit the people who benefit from more needs.

本发明专利成果养生口服液成果价值：经中国科技咨询协会技术成果评价工作委员会与北京瑞沃投资顾问有限公司联合作出了成果评价报告表明：该发明专利技术成果是属于具有药食同源功能性保健食品，对人体健康有特殊的意义，对冠心病起到独到之处的治愈的效果，它技术含量高，研究时间长，毫资费用大，特别是该技术成果具有接产投产快，市场需求大，投资风险小，回报效益高，符合国家当今的战略部署。因此评定该专利技术成果价值为2亿元人民币。并且该专利市场有效期足有10年。而专利权人钟毓原先生表示，为了鼓励接产方全力面向大健康产业服务，造福更多的患者，以最优惠的价格转化专利技术，转让起点价为0.15亿元，出价高者获得。

The invention patent achievement health oral liquid achievement value: the China association of science and technology consulting technology achievements evaluation committee and Beijing investment advisory co., LTD. Jointly made the results evaluation report shows that the invention patent technology is belong to have medicine food homologous functional health food, has special significance to the human health, the coronary heart disease unique cure effect, it has high technical content, a long research time, charges with large, especially the technology with production fast, market demand, small investment risk, high return benefit, in line with the country today's strategic deployment. Therefore, the value of the patented technology achievement is assessed at 200 million yuan. And the patent market is valid for 10 years. Mr.Zhong Yuyuan, the patentee, said that in order to encourage the supplier to serve the big health industry and benefit more patients, the patented technology at the most favorable price, the starting price was 15 million yuan, and the higher bidder.

这是多年的冠心病患者应用中医养生素口服液调理，都一一得到康复治愈，六年时间从没复发，平安无事，免去了支架丶搭桥丶西药的毒副作用，功德善人造福天下人。

This is many years of coronary heart disease patients use of traditional Chinese medicine health care oral liquid conditioning, one by one to be cured, six years never relapse, safe, without stents, bypass, western medicine from the toxic side effects, good people benefit the people of the world.

钟毓原先生受中华国际医学医学基金会邀请参加全国第三届中医药论坛贵宾，受到国家领导人丶人大副委员长顾秀莲丶桑囯卫丶阿不来提的亲切接见。左排后一是养生素创新发明人钟毓原先生

Mr.Zhong Yuyuan was invited by the China International Medical Foundation to attend the third National Chinese Medicine Forum, and was warmly received by state leaders, Vice Chairman of the National People's Congress Gu Xiulian, Sang and Alaiti. In the left row is Mr.Zhong Yuyuan, the innovative inventor of health element

联系电话微信号：13657825132。专利权人：钟毓原。

Contact phone number: WeChat ID: 13657825132. Patentee: Zhong Yuyuan.

本期报道编者王春霞

This report editor Wang Chunxia

来源：本站